Long-Term Outcome of Photobiomodulation for Diabetic Macular Edema: A Case Report.

Masoumeh Ahadi, Afsaneh Ebrahimi, Shahrokh Ramin
{"title":"Long-Term Outcome of Photobiomodulation for Diabetic Macular Edema: A Case Report.","authors":"Masoumeh Ahadi,&nbsp;Afsaneh Ebrahimi,&nbsp;Shahrokh Ramin","doi":"10.1089/photob.2022.0059","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Macular edema is the major cause of decreased vision in patients with diabetes. Antioxidative and anti-inflammatory effects of photobiomodulation (PBM) have been reported with near-infrared irradiation. <b><i>Objective:</i></b> In this study, the efficacy and safety of PBM with near-infrared radiation in a patient with diabetic macular edema were assessed. <b><i>Methods:</i></b> We present the case of a 60-year-old man with diabetic macular edema responding to 670 nm light PBM alone. <b><i>Results:</i></b> After PBM, his vision improved and macular edema resolved on optical coherence tomography (OCT) findings without adverse events. In 16 months follow-up, visual acuity remained stable and OCT showed no evidence of recurrence of edema. <b><i>Conclusions:</i></b> Six hundred seventy nanometers light PBM can be potentially considered as a therapeutic method in diabetic patients with macular edema. Also, it provides a noninvasive and nonexpensive treatment in home.</p>","PeriodicalId":20111,"journal":{"name":"Photobiomodulation, photomedicine, and laser surgery","volume":" ","pages":"742-746"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photobiomodulation, photomedicine, and laser surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/photob.2022.0059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Macular edema is the major cause of decreased vision in patients with diabetes. Antioxidative and anti-inflammatory effects of photobiomodulation (PBM) have been reported with near-infrared irradiation. Objective: In this study, the efficacy and safety of PBM with near-infrared radiation in a patient with diabetic macular edema were assessed. Methods: We present the case of a 60-year-old man with diabetic macular edema responding to 670 nm light PBM alone. Results: After PBM, his vision improved and macular edema resolved on optical coherence tomography (OCT) findings without adverse events. In 16 months follow-up, visual acuity remained stable and OCT showed no evidence of recurrence of edema. Conclusions: Six hundred seventy nanometers light PBM can be potentially considered as a therapeutic method in diabetic patients with macular edema. Also, it provides a noninvasive and nonexpensive treatment in home.

光生物调节治疗糖尿病性黄斑水肿的长期疗效:1例报告。
背景:黄斑水肿是糖尿病患者视力下降的主要原因。近红外辐照对光生物调节(PBM)的抗氧化和抗炎作用已有报道。目的:评价近红外辐射PBM治疗糖尿病黄斑水肿的疗效和安全性。方法:我们报告一例60岁男性糖尿病性黄斑水肿,仅对670 nm光PBM有反应。结果:在PBM后,他的视力得到改善,黄斑水肿在光学相干断层扫描(OCT)上得到缓解,无不良事件。随访16个月,视力保持稳定,OCT未见水肿复发。结论:670纳米光PBM可作为糖尿病黄斑水肿的一种治疗方法。此外,它提供了一种无创和不昂贵的家庭治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信